AE11196
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1mg | 98% | in stock | $100.00 | $70.00 | - + | |
5mg | 98% | in stock | $129.00 | $90.00 | - + | |
10mg | 98% | in stock | $168.00 | $117.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AE11196 |
Chemical Name: | E-3810 |
CAS Number: | 1058137-23-7 |
Molecular Formula: | C26H25N3O4 |
Molecular Weight: | 443.4944 |
MDL Number: | MFCD09607817 |
SMILES: | CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1 |
Lucitanib, a potent and selective inhibitor of vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR), is a valuable tool in chemical synthesis. Its ability to modulate cellular signaling pathways involved in angiogenesis and tumor growth makes it a crucial component in drug discovery and development efforts. Lucitanib's unique pharmacological profile offers researchers the opportunity to explore novel synthetic routes and molecular mechanisms, leading to the development of innovative pharmaceuticals with improved efficacy and safety profiles. Its application in chemical synthesis opens doors to the creation of new therapeutic agents targeting a range of diseases, including cancer and cardiovascular disorders. By incorporating Lucitanib into synthetic strategies, chemists can harness its molecular properties to design next-generation drugs that hold promise for improving patient outcomes and advancing the field of medicinal chemistry.